5556-89-8

Usage

Uses

Used in Pharmaceutical Industry:
(2E)-3-(4-methoxyphenyl)-N-[2-(phenylethynyl)phenyl]prop-2-enamide is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activities. It acts as an inhibitor of the enzyme fatty acid amide hydrolase (FAAH), which is involved in the regulation of endocannabinoid signaling. This makes it a promising candidate for the development of drugs targeting various medical conditions.
Used in Agrochemical Industry:
In the agrochemical industry, (2E)-3-(4-methoxyphenyl)-N-[2-(phenylethynyl)phenyl]prop-2-enamide is used as a building block in the synthesis of agrochemicals. Its potential biological activities can be harnessed to develop new pesticides or other agrochemical products that can improve crop yield and protect plants from pests and diseases.
Used in Research and Development:
(2E)-3-(4-methoxyphenyl)-N-[2-(phenylethynyl)phenyl]prop-2-enamide is also used in research and development for studying its potential anti-inflammatory and analgesic properties. This can lead to the discovery of new therapeutic agents for the treatment of pain and inflammation-related disorders.

Upstream product

• 4460-86-0 asaraldehyde 
• 109-77-3 malononitrile 

Downstream Products

• 1221564-25-5 4-[2-amino-3-cyano-4-(2,4,5-trimethoxyphenyl)-5-oxo-5,6,7,8-tetrahydroquinolin-1(4H)-yl]benzenesulfonamide 

Relevant academic research and scientific papers

Physicochemical Investigation of 2,4,5-Trimethoxybenzylidene Propanedinitrile (TMPN) Dye as Fluorescence off-on Probe for Critical Micelle Concentration (CMC) of SDS and CTAB

2,4,5-trimethoxybenzylidene propanedinitrile (TMPN) was synthesized by Knoevenagel condensation. Structure of the TMPN was conformed by the elemental analysis and EI-MS, FT-IR, 1H-NMR, 13C-NMR spectroscopy. Absorbance and emission sp

Pseudo-five-component organocatalyzed synthesis of dicyanoanillines using only malononitrile and aromatic aldehydes

A pseudo-five-component reaction leading to efficient synthesis of dicyanoanillines was developed using only aromatic aldehydes and malononitrile as the starting reactants. Mechanistic studies suggested that a malononitrile dimer and the Knoevenagel conde

NOVEL COMPOUND FOR PREVENTING OR TREATING NEUROINFLAMMATORY DISEASE AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME

A 2, 4, 5 -trihydroxyphenyl acrylate analog and a composition for preventing or treating neuroinflammatory diseases containing the same as an active ingredient are provided. A composition comprising LPS -stimulated BV-2 microglia NO-stimulated iNOS-2 micr

Synthesis of substituted 6-amino-4-aryl-5-cyano-2h,4h-pyrano[2,3-c]pyrazoles. Crystal and molecular structure of 6-amino-5-cyano-3-methyl-4-(2′,4′,6′-triethylphenyl)-2h,4h -pyrano[2,3-c]pyrazole

Substituted 6-aminopyrano[2,3-c]pyazoles were synthesized by the two-component condensation of arylidenemalononitriles and substituted 5-pyazolones or three-component condensation of aromatic aldehydes, malononitrile, and substituted 5-pyazolones. It was